Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;54(1):25-31.
doi: 10.5946/ce.2021.021. Epub 2021 Jan 29.

Various Novel and Emerging Technologies in Endoscopic Bariatric and Metabolic Treatments

Hee Kyong Na  1 , Diogo Turiani Hourneaux De Moura  2 ; Study Group for Endoscopic Bariatric and Metabolic Therapies of the Korean Society of Gastrointestinal Endoscopy
Affiliations

Various Novel and Emerging Technologies in Endoscopic Bariatric and Metabolic Treatments

Hee Kyong Na et al. Clin Endosc. 2021 Jan.

Abstract

Obesity, along with its comorbidities, has become a significant public health concern worldwide. Bariatric surgery is considered the most effective treatment modality; however, only 2% of patients with obesity undergo bariatric surgery. Endoscopic bariatric and metabolic therapies (EBMTs) are emerging alternatives to traditional bariatric surgery for patients who are not eligible for or do not prefer surgical treatment. EBMTs are generally categorized as space-occupying, gastric restrictive, aspiration, and small bowel therapies. We aimed to review various non-balloon and non-gastroplasty devices with available clinical data and discuss the possible mechanisms of action, efficacy, and safety profile of these EMBTs.

Keywords: Bariatric; Endoscopy; Metabolic; Obesity; Weight loss.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no financial conflicts of interest.

Figures

Fig. 1.
Fig. 1.
Aspiration therapy.
Fig. 2.
Fig. 2.
Duodenal-jejunal bypass liner.
Fig. 3.
Fig. 3.
Gastroduodenojejunal bypass sleeve.
Fig. 4.
Fig. 4.
Duodenal mucosal resurfacing.
Fig. 5.
Fig. 5.
Incisionless magnetic anastomosis system.
See this image and copyright information in PMC

References

    1. Bray GA, Frühbeck G, Ryan DH, Wilding JP. Management of obesity. Lancet. 2016;387:1947–1956. - PubMed
    1. Prospective Studies Collaboration. Whitlock G, Lewington S, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083–1096. - PMC - PubMed
    1. ASGE/ASMBS Task Force on Endoscopic Bariatric Therapy. Ginsberg GG, Chand B, et al. A pathway to endoscopic bariatric therapies. Gastrointest Endosc. 2011;74:943–953. - PubMed
    1. Gastrointestinal surgery for severe obesity. Consens Statement 1991;9:1-20. - PubMed
    1. Arterburn DE, Telem DA, Kushner RF, Courcoulas AP. Benefits and risks of bariatric surgery in adults: a review. JAMA. 2020;324:879–887. - PubMed

LinkOut - more resources